Rocío Granda‐Díaz

600 total citations
20 papers, 374 citations indexed

About

Rocío Granda‐Díaz is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Rocío Granda‐Díaz has authored 20 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Otorhinolaryngology. Recurrent topics in Rocío Granda‐Díaz's work include Cancer-related gene regulation (10 papers), RNA modifications and cancer (5 papers) and Head and Neck Cancer Studies (4 papers). Rocío Granda‐Díaz is often cited by papers focused on Cancer-related gene regulation (10 papers), RNA modifications and cancer (5 papers) and Head and Neck Cancer Studies (4 papers). Rocío Granda‐Díaz collaborates with scholars based in Spain, United Kingdom and China. Rocío Granda‐Díaz's co-authors include Juana García-Pedrero, Juan P. Rodrigo, Francisco Hermida‐Prado, Eva Allonca, M. Ángeles Villaronga, Saúl Álvarez–Teijeiro, Sofía T. Menéndez, Luis M. Montuenga, Irati Garmendia and Christian Sordo‐Bahamonde and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Molecular Cancer.

In The Last Decade

Rocío Granda‐Díaz

19 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rocío Granda‐Díaz Spain 12 182 174 93 66 48 20 374
Saúl Álvarez–Teijeiro Spain 14 322 1.8× 121 0.7× 142 1.5× 42 0.6× 48 1.0× 29 450
Michael M. Allevato United States 7 178 1.0× 145 0.8× 61 0.7× 79 1.2× 56 1.2× 15 336
Simona Nuzzo Italy 7 222 1.2× 214 1.2× 84 0.9× 65 1.0× 46 1.0× 10 388
Sung‐Wei Lee Taiwan 14 283 1.6× 155 0.9× 174 1.9× 37 0.6× 104 2.2× 38 492
Irina Abécassis United States 6 147 0.8× 186 1.1× 80 0.9× 154 2.3× 41 0.9× 7 371
Naohisa Oku Japan 6 204 1.1× 126 0.7× 153 1.6× 21 0.3× 35 0.7× 16 399
Cera Nieto United States 9 198 1.1× 136 0.8× 101 1.1× 69 1.0× 89 1.9× 10 349
Yaoyun Tang China 9 329 1.8× 75 0.4× 178 1.9× 29 0.4× 44 0.9× 13 426
Tugs‐Saikhan Chimed United States 8 184 1.0× 143 0.8× 85 0.9× 79 1.2× 32 0.7× 9 304
Priscillia Battiston-Montagne France 12 234 1.3× 136 0.8× 133 1.4× 25 0.4× 199 4.1× 16 477

Countries citing papers authored by Rocío Granda‐Díaz

Since Specialization
Citations

This map shows the geographic impact of Rocío Granda‐Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Granda‐Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Granda‐Díaz more than expected).

Fields of papers citing papers by Rocío Granda‐Díaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocío Granda‐Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Granda‐Díaz. The network helps show where Rocío Granda‐Díaz may publish in the future.

Co-authorship network of co-authors of Rocío Granda‐Díaz

This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Granda‐Díaz. A scholar is included among the top collaborators of Rocío Granda‐Díaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Granda‐Díaz. Rocío Granda‐Díaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sordo‐Bahamonde, Christian, Rocío Granda‐Díaz, Jesús Pascual, et al.. (2025). The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia. Biomedicine & Pharmacotherapy. 189. 118253–118253. 1 indexed citations
2.
Granda‐Díaz, Rocío, et al.. (2024). Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements. Biomarker Research. 12(1). 126–126. 3 indexed citations
3.
Granda‐Díaz, Rocío, Sofía T. Menéndez, Aida Rodríguez, et al.. (2024). Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading. International Journal of Molecular Sciences. 25(5). 2695–2695. 2 indexed citations
4.
Sordo‐Bahamonde, Christian, Seila Lorenzo‐Herrero, Rocío Granda‐Díaz, et al.. (2023). Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy. Molecular Cancer. 22(1). 142–142. 46 indexed citations
5.
Granda‐Díaz, Rocío, Lorea Manterola, Francisco Hermida‐Prado, et al.. (2023). Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways. Biomedicine & Pharmacotherapy. 161. 114512–114512. 9 indexed citations
6.
García-Pedrero, Juana, M. Ángeles Villaronga, Francisco Hermida‐Prado, et al.. (2020). Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. Acta Otorrinolaringologica (English Edition). 71(6). 358–366. 1 indexed citations
7.
García-Pedrero, Juana, M. Ángeles Villaronga, Francisco Hermida‐Prado, et al.. (2020). Expresión de E-cadherina y β-catenina en carcinomas de células escamosas de laringe e hipofaringe. Acta Otorrinolaringológica Española. 71(6). 358–366.
8.
Granda‐Díaz, Rocío, Eva Allonca, Fernando López, et al.. (2020). PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas. Cancer Immunology Immunotherapy. 69(10). 2089–2100. 48 indexed citations
9.
Granda‐Díaz, Rocío, et al.. (2020). Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application. Reviews of physiology, biochemistry and pharmacology. 181. 375–427. 12 indexed citations
10.
Hermida‐Prado, Francisco, Rocío Granda‐Díaz, Eva Allonca, et al.. (2020). Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas. Cancers. 12(7). 1794–1794. 24 indexed citations
11.
Vicente, Juan Carlos de, Juan P. Rodrigo, Eva Allonca, et al.. (2019). SOX2 Expression Is an Independent Predictor of Oral Cancer Progression. Journal of Clinical Medicine. 8(10). 1744–1744. 37 indexed citations
12.
Hermida‐Prado, Francisco, Rocío Granda‐Díaz, M. Ángeles Villaronga, et al.. (2019). The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma. Cancers. 11(11). 1644–1644. 11 indexed citations
13.
Hermida‐Prado, Francisco, M. Ángeles Villaronga, Rocío Granda‐Díaz, et al.. (2019). The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042. Journal of Clinical Medicine. 8(8). 1157–1157. 17 indexed citations
14.
Menéndez-Menéndez, Javier, Francisco Hermida‐Prado, Rocío Granda‐Díaz, et al.. (2019). Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin. Cancers. 11(7). 1011–1011. 37 indexed citations
15.
Granda‐Díaz, Rocío, Sofía T. Menéndez, Francisco Hermida‐Prado, et al.. (2019). The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions. Cancers. 11(3). 286–286. 12 indexed citations
16.
Hermida‐Prado, Francisco, Sofía T. Menéndez, Rocío Granda‐Díaz, et al.. (2018). Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients. Journal of Clinical Medicine. 7(12). 501–501. 17 indexed citations
17.
Villaronga, M. Ángeles, Francisco Hermida‐Prado, Rocío Granda‐Díaz, et al.. (2018). Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading. Cancer Epidemiology Biomarkers & Prevention. 27(7). 805–813. 18 indexed citations
18.
Álvarez–Teijeiro, Saúl, Cristina García–Inclán, M. Ángeles Villaronga, et al.. (2018). Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets. Cancers. 10(9). 334–334. 49 indexed citations
19.
Álvarez–Teijeiro, Saúl, Sofía T. Menéndez, M. Ángeles Villaronga, et al.. (2017). Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b. Scientific Reports. 7(1). 6790–6790. 26 indexed citations
20.
García-Pedrero, Juana, M. Ángeles Villaronga, Francisco Hermida‐Prado, et al.. (2017). Prognostic significance of E‐cadherin and β‐catenin expression in HPV‐negative oropharyngeal squamous cell carcinomas. Head & Neck. 39(11). 2293–2300. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026